Actively Recruiting
Eccentric Cycling Exercise During Pulmonary Rehabilitation in Patients With Cardiopulmonary Diseases
Led by Silvia Ulrich Somaini · Updated on 2025-06-29
24
Participants Needed
2
Research Sites
56 weeks
Total Duration
On this page
Sponsors
S
Silvia Ulrich Somaini
Lead Sponsor
K
Klinik Barmelweid
Collaborating Sponsor
AI-Summary
What this Trial Is About
Eccentric cycling exercise (ECC) allows training at low metabolic costs and may therefore be valuable for patients with pulmonary vascular disease (PVD). For these patients, regular exercise training has an evidence level 1A recommendation in the current guidelines. Exercise training during longer and regular periods provides chronic adaptation, for which ECC was recently found to have a greater effectiveness than CON by increasing muscle strength, hypertrophy, six-minute walking distance and furthermore, by increasing maximum oxygen uptake (V'O2max) especially in patients with chronic obstructive pulmonary disease (COPD), chronic left heart failure or coronary heart disease. Furthermore, we conducted an RCT in which we exposed patients with PVD to ECC and concluded that ECC is a feasible and well-tolerated exercise modality for PVD patients with severely lower O2 demand and load to the right ventricle. The study in patients with PVD was started (EccRehab), and the great potential was recognized. Therefore there was an indication to open the inclusion criteria to all cardiopulmonary patients with indication for pulmonary rehabilitation (EccRehab2). For this purpose, the aim of this project is to investigate whether ECC improves exercise capacity and possibly hemodynamics during prolonged rehabilitation programs in patients with cardiopulmonary diseases.
CONDITIONS
Official Title
Eccentric Cycling Exercise During Pulmonary Rehabilitation in Patients With Cardiopulmonary Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with pulmonary vascular disease (PAH or CTEPH) confirmed by right heart catheterization according to recent guidelines
- Diagnosed with a cardiopulmonary disease requiring pulmonary rehabilitation
- Stable medication for at least 1 month
- Aged 18 to 85 years
- No resting hypoxemia (PaO2 greater than 7.3 kPa)
- Medical indication to prescribe pulmonary rehabilitation
You will not qualify if you...
- Any co-morbidity that limits full participation in the rehabilitation
- Participation in other clinical trials with active treatments
- Language barriers that limit participation in the rehabilitation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Klinik Barmelweid
Barmelweid, Switzerland, 5017
Actively Recruiting
2
Universitätsspital Zürich
Zurich, Switzerland, 8092
Actively Recruiting
Research Team
S
Silvia Ulrich, Prof. dr. med.
CONTACT
J
Julian Müller, Dr. sc. med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here